Dopaminergic agents are the best-studied agents and are considered first-line treatment of restless legs syndrome (RLS). Extensive data are available for levodopa, pramipexole, and ropinirole, which have approval for the indication RLS, and to a smaller extent for cabergoline, pergolide, and rotigot
Prevalence of the restless legs syndrome in transsexual patients: the hormonal hypothesis revisited
β Scribed by S. Fulda; G. K. Stalla; T. C. Wetter
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 214 KB
- Volume
- 254
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract To explore the clinical significance of restless legs syndrome (RLS) in Parkinson's disease (PD) and the causal relationship between these two disorders, we made a comparison of both the prevalence of RLS and the severity of sleep disturbance manifested on the Pittsburg Sleep Quality In
We read with interest the recent report by Nomura and colleagues. 1 Their study provided extensive data on the prevalence and clinical characteristics of restless legs syndrome (RLS) in Japanese patients with Parkinson's disease (PD). They found 20 PD patients who also had a diagnosis of RLS, but on
The impressive relief from restless legs syndrome (RLS) symptoms provided by levodopa treatment indicates RLS is caused by a dopaminergic abnormality. But similar and more lasting relief also occurs for iron treatment in some patients. Thus there are two major putative causes for RLS: CNS dopaminerg
## Abstract Although restless legs syndrome (RLS) commonly accompanies Parkinson disease (PD), the mechanism of RLS development in PD is still unclear. We investigated the prevalence of RLS in Korean patients with PD, and the possible contributing factors to the development of RLS in those patients